SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Vivesto Secures US Orphan Drug Designation for Cantrixil

Vivesto said it received US orphan drug designation for Cantrixil in acute myeloid leukemia.

Related stories